Global Diverticular Disease Market Insights Forecasts to 2033

• The Global Diverticular Disease Market Size was Valued at USD 1.68 Billion in 2023
• The Market Size is Growing at a CAGR of 8.24% from 2023 to 2033
• The Worldwide Diverticular Disease Market Size is Expected to Reach USD 3.71 Billion by 2033
• Asia Pacific is Expected to Grow the fastest during the forecast period.

The Global Diverticular Disease Market Size is Anticipated to Exceed USD 3.71 Billion by 2033, Growing at a CAGR of 8.24% from 2023 to 2033.

Market Overview

Diverticulum is a Latin term meaning a side branch or pouch and is a condition where pouches stick outwards from the large intestine (colon) wall. These pouches resemble a bicycle tire with a soft, easily stretched inner tube and a tough outer tube. If a hole is made in the outer tube, the inner tube inflates and squeezes out through the hole. The intestine has a soft, flexible lining surrounded by a tougher outer tube of muscle. If there is a weakness in the muscle, the inner layer can push through it to form a diverticulum. Diverticula are used when there is more than one diverticulum in the bowel. The contributing factors for the diverticular disease market include the increasing prevalence of gastrointestinal disorders due to aging populations and unhealthy dietary habits, particularly in developed countries. Rising awareness about gastrointestinal health, advances in diagnostic techniques, and improvements in treatment options, including minimally invasive procedures, also contribute to market growth. Additionally, the growing demand for pharmaceuticals, including antibiotics and anti-inflammatory drugs, and the emphasis on preventive care and lifestyle modifications further support the expansion of this market.

Report Coverage

This research report categorizes the market for the global diverticular disease market based on various segments and regions forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the global diverticular disease market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the global diverticular disease market.

Driving Factors

The diverticular disease market is being driven by an increase in the incidences of gastrointestinal illnesses as a result of aging populations and bad eating patterns in advanced economies. Rising awareness of gastrointestinal health, breakthroughs in diagnostic tools, and improvements in treatment choices, such as less invasive treatments, all help to drive market expansion. Furthermore, rising demand for medicines, such as antibiotics and anti-inflammatory medications, as well as a focus on preventative care and lifestyle changes, all contribute to the market's growth.

Restraining Factors

The restraining factors for the diverticular disease market include the high costs associated with advanced diagnostic tools and treatment options, which can limit accessibility for certain patient populations. Lack of awareness about the disease, especially in developing regions, also hinders early diagnosis and treatment. Additionally, potential side effects and complications from surgical interventions and long-term drug use, such as antibiotic resistance, may reduce patient compliance.

Market Segmentation

The global diverticular disease market share is classified into diagnosis, treatment, and end-user.

• The CT scan segment is expected to hold the largest share of the global diverticular disease market during the forecast period.   

Based on the diagnosis, the global diverticular disease market is divided into physical examination, CT scan, colonoscopy, and blood tests. Among these, the CT scan segment is expected to hold the largest share of the global diverticular disease market during the forecast period. CT scan are expected to experience significant growth in the diverticular disease diagnosis market due to their ability to provide detailed imaging for accurate diagnosis of diverticular complications like abscesses, perforations, and fistulas. The increasing adoption of non-invasive techniques and technological advancements in imaging are driving demand for this segment.

• The medication segment is expected to grow at the fastest CAGR in the global diverticular disease market during the forecast period.   

Based on the treatment, the global diverticular disease market is divided into medication, surgery, and dietary changes. Among these, the medication segment is expected to grow at the fastest CAGR in the global diverticular disease market during the forecast period. The medication segment in the global diverticular disease market is expected to grow significantly due to the increasing reliance on pharmaceutical interventions like antibiotics, anti-inflammatory drugs, and pain relievers. The demand for non-invasive treatment options, particularly in the early stages, is also increasing. Advancements in drug formulations and increased awareness contribute to the expansion of this segment.

• The hospital segment is expected to grow at the fastest CAGR in the global diverticular disease market during the forecast period.   

Based on the end-user, the global diverticular disease market is divided into hospitals, ambulatory surgical centers, and specialty clinics. Among these, the hospital segment is expected to grow at the fastest CAGR in the global diverticular disease market during the forecast period. Hospitals are expected to experience significant growth in the diverticular disease market due to advanced diagnostic tools and treatment facilities. The increasing incidence of diverticulitis requiring hospitalization, preference for specialized care, and rising healthcare expenditure in developing regions make hospitals the primary destination for treatment.

Regional Segment Analysis of the Global Diverticular Disease Market

• North America (U.S., Canada, Mexico) 
• Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
• Asia-Pacific (China, Japan, India, Rest of APAC)
• South America (Brazil and the Rest of South America) 
• The Middle East and Africa (UAE, South Africa, Rest of MEA)

North America is anticipated to hold the largest share of the global diverticular disease market over the predicted timeframe.

North America is anticipated to hold the largest share of the global diverticular disease market over the predicted timeframe. The region is expected to dominate the global diverticular disease market due to its high prevalence, advanced healthcare infrastructure, access to diagnostic tools, and strong pharmaceutical market. Factors like aging populations, low-fiber diets, and increased awareness about gastrointestinal health contribute to its dominance. Key market players also play a significant role.

Asia Pacific is expected to grow at the fastest pace in the global diverticular disease market during the forecast period. The region is expected to experience the fastest growth in the global diverticular disease market due to factors such as an aging population, gastrointestinal disorders, and westernized dietary habits. The region is also experiencing improvements in healthcare infrastructure and access to advanced diagnostic tools. The growing awareness about digestive health and the expanding pharmaceutical sector in countries like China, Japan, and India further contribute to this growth.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the global diverticular disease market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• Pfizer Inc.
• AbbVie Inc.
• Novartis AG
• Johnson & Johnson
• Takeda Pharmaceutical Company Limited
• Sanofi S.A.
• AstraZeneca plc
• Bayer AG
• Bristol-Myers Squibb Company
• GlaxoSmithKline plc
• F. Hoffmann-La Roche Ltd
• Teva Pharmaceutical Industries Ltd.
• Mylan N.V.
• Allergan plc
• Merck & Co., Inc.
• Others

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting And Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Recent Developments

• In January 2020, Emmaus Life Sciences disclosed a preliminary emphasis on diverticulitis treatment outcomes, with the first patient seeking to study the treatment within the company's scope.

• In May 2020, Hikma Pharmaceuticals PLC introduced the Dicyclomine Hydrochloride oral solution for improved treatment of various inflammatory diagnoses of bowel diseases.

Market Segment

This study forecasts revenue at global, regional, and country levels from 2020 to 2033. Spherical Insights has segmented the global Diverticular disease market based on the below-mentioned segments: 

Global Diverticular Disease Market, By Diagnosis

• Physical Examination
• CT Scan
• Colonoscopy
• Blood Tests

Global Diverticular Disease Market, By Treatment

• Medication
• Surgery
• Dietary Changes

Global Diverticular Disease Market, By End-User

• Hospitals
• Ambulatory Surgical Centers
• Specialty Clinics

Global Diverticular Disease Market, Regional

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Qatar
  • South Africa
  • Rest of the Middle East & Africa